Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1993 1
1994 2
1995 1
1996 3
1997 1
1998 2
1999 5
2000 2
2005 6
2006 2
2007 4
2008 4
2009 2
2010 2
2011 5
2012 5
2013 6
2014 5
2015 5
2016 3
2018 2
2019 3
2020 9
2021 10
2022 9
2023 7
2024 10
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

102 results

Results by year

Filters applied: . Clear all
Page 1
A case of EBV-associated adrenal leiomyoma.
Takemoto T, Kiriyama I, Sugawara Y, Abe C, Teramoto N, Hashine K, Yoshida I, Asagi A. Takemoto T, et al. Among authors: hashine k. Radiol Case Rep. 2024 Mar 16;19(6):2224-2229. doi: 10.1016/j.radcr.2024.02.044. eCollection 2024 Jun. Radiol Case Rep. 2024. PMID: 38523717 Free PMC article.
Outcomes of active surveillance for Japanese patients with prostate cancer (PRIAS-JAPAN).
Kato T, Matsumoto R, Yokomizo A, Tohi Y, Fukuhara H, Fujii Y, Mori K, Sato T, Inokuchi J, Hashine K, Sakamoto S, Kinoshita H, Inoue K, Tanikawa T, Utsumi T, Goto T, Hara I, Okuno H, Kakehi Y, Sugimoto M. Kato T, et al. Among authors: hashine k. BJU Int. 2024 Oct;134(4):652-658. doi: 10.1111/bju.16436. Epub 2024 Jun 17. BJU Int. 2024. PMID: 38886979
Effect of HLA Genotype on Anti-PD-1 Antibody Treatment for Advanced Renal Cell Carcinoma in the SNiP-RCC Study.
Tanegashima T, Shiota M, Fujiyama N, Narita S, Habuchi T, Fukuchi G, Takamatsu D, Oda Y, Miyake H, Takahashi M, Oya M, Tsuchiya N, Masumori N, Matsuyama H, Obara W, Shinohara N, Fujimoto K, Nozawa M, Ohba K, Ohyama C, Hashine K, Akamatsu S, Kamba T, Mita K, Gotoh M, Tatarano S, Fujisawa M, Tomita Y, Mukai S, Ito K, Tokunaga S, Eto M. Tanegashima T, et al. Among authors: hashine k. J Immunol. 2024 Jul 1;213(1):23-28. doi: 10.4049/jimmunol.2300308. J Immunol. 2024. PMID: 38758119 Free PMC article.
[PATIENT-REPORTED OUTCOME AFTER ILEAL NEOBLADDER].
Tomida R, Arai O, Iuchi S, Matsumura M, Hashine K. Tomida R, et al. Among authors: hashine k. Nihon Hinyokika Gakkai Zasshi. 2020;111(4):107-113. doi: 10.5980/jpnjurol.111.107. Nihon Hinyokika Gakkai Zasshi. 2020. PMID: 34670908 Free article. Japanese.
Long-term outcomes of the first prospective study of active surveillance for prostate cancer in Japan.
Kato T, Hirama H, Kamoto T, Goto T, Fujimoto H, Sakamoto S, Shinohara N, Egawa S, Kouguchi D, Nakayama M, Hashine K, Shimizu N, Inoue K, Habuchi T, Hioka T, Shiraishi T, Sugimoto M, Kakehi Y. Kato T, et al. Among authors: hashine k. Int J Clin Oncol. 2024 Oct;29(10):1557-1563. doi: 10.1007/s10147-024-02590-4. Epub 2024 Aug 1. Int J Clin Oncol. 2024. PMID: 39085727
Reproductive organ involvement in women undergoing radical cystectomy for urothelial bladder cancer: a nationwide multicenter study.
Kato M, Taoka R, Miki J, Saito R, Fukuokaya W, Matsui Y, Yamamoto S, Matsue T, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Yamamoto S, Yasue K, Abe T, Nakanishi S, Hashine K, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Uchida J; Japan Urological Oncology Group. Kato M, et al. Among authors: hashine k. Int J Clin Oncol. 2024 Dec;29(12):1937-1945. doi: 10.1007/s10147-024-02636-7. Epub 2024 Oct 9. Int J Clin Oncol. 2024. PMID: 39379757
102 results